A fourth dose of mRNA COVID-19 vaccine seems safe for immunocompromised individuals aged 12 years or older, according to research published in the July 15 issue of the U.S. Centers for Disease Control and Prevention Morbidity ...
Jul 18, 2022
0
2
Two broadly neutralizing antibodies show great promise to provide long-acting immunity against COVID-19 in immunocompromised populations according to a paper published June 15 in the Journal of Experimental Medicine (JEM). ...
Jun 15, 2022
0
5
One thousand confirmed cases of monkeypox, a disease originating in Africa, have been recorded since early May across at least 30 non-endemic countries such as the United Kingdom, Spain, Portugal, France, the United States, ...
Jun 7, 2022
0
38
According to a new study published today in Blood Advances, frailty assessments, a type of geriatric exam essential to predicting health outcomes in older adults with cancer, are both safe and feasible when conducted virtually. ...
May 26, 2022
0
3
The longest known COVID-19 infection is described by UK researchers at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal, (23-26 April).
Apr 22, 2022
0
24
CoVac-1, a new vaccine against SARS-CoV-2, induced T-cell immune responses in 93 percent of patients with B-cell deficiencies, including many patients with leukemia and lymphoma, according to results presented at the AACR ...
Apr 12, 2022
0
6
For severely immunocompromised patients, a bone marrow transplant restores immune defenses and allows them to resume normal life. But after observing the nasopharyngeal system, where the body's first line of immune defense ...
Apr 4, 2022
0
4
On March 29 the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) approved the use of a second COVID-19 booster shot for adults over age 50 and certain immunocompromised individuals, ...
Mar 30, 2022
0
14
A team of scientists at the Yale Schools of Medicine and Public Health has identified a remdesivir-resistant variant of SARS-CoV-2, the virus that causes COVID-19, in an immunocompromised patient who was being treated with ...
Mar 23, 2022
0
131
Spare a thought for patients with impaired immunity during the COVID-19 pandemic. Their condition puts them at high risk of severe complications from COVID-19, but also creates uncertainty about the safety and effectiveness ...
Mar 17, 2022
0
10
